Drawing for FLEXSTAR

USPTO serial 79311993

FLEXSTAR

Reviewed by CopyMark Law Group

Reg. 7215162Status 700Registered
Filing date
Status date
Registration date
Nov 14, 2023
Examiner
FITZSIMONS, MICHAEL R
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with FLEXSTAR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew J. Smith

Matthew J. Smith Polsinelli PCPO BOX 140310Kansas City, MO 64114-0310UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biological and chemical substances, for industrial, scientific and research purposes, namely, nucleic acids, enzymes, polymerases, reagents for staining or marking, molecular probes, buffer, aqueous and non-aqueous solutions of alcohols and salts, distilled and purified water, silica in powdered, granulate and gel form, and magnetic particles in fluid form, for laboratory and research use; enzymes and preparations for polymerase chain reaction (PCR) for chemical purposes; diagnostic preparations for scientific or research purposes; diagnostic substances in the nature of reagents for scientific or research purposes; all the aforementioned goods for industrial or scientific purposesACTIVE—
005Pharmaceutical and veterinary preparations, namely, biological substances and chemicals for use in medical purposes and medical in vitro diagnostics purposes, namely, nucleic acids, enzymes, polymerases, molecular probes, buffer, aqueous and non-aqueous solutions of alcohols and salts, distilled and purified water, silica in powdered, granulate and gel form, magnetic particles in fluid form; in-vitro diagnostic preparations for medical purposes; diagnostic preparations for medical purposes; enzymes and preparations being diagnostic preparations for polymerase chain reaction (PCR) for medical purposes; all the aforementioned goods for medical or veterinary purposesACTIVE—
009Scientific apparatus and instruments for laboratory use and for the conducting and evaluation of diagnostic examinations for medical laboratory and scientific purposes, namely, thermocyclers, for marking, separating, isolating, purifying, amplifying, and analyzing biopolymers, in particular, nucleic acids, proteins, macro molecules and biologically active substances, for laboratory or research use and computer hardware and recorded computer operating software for scientific apparatus, instruments and equipment; scientific apparatus and instruments for laboratory use, for use in amplification procedures by use of polymerase chain reaction (PCR); plastic goods for laboratories, in particular microplates with and without reagents for laboratory use; lids for microplates; sealing foils for microplates; all the aforementioned goods for use in scientific research, clinical laboratory, medical research or non-medical diagnostic applicationsACTIVE—
042Scientific and technological services and research services, namely, scientific research, analysis and testing in the field of clinical, veterinary, environmental and medical diagnosis in the field of molecular biology; technological consultancy services for scientific, technical laboratory and research purposes, namely, technological consulting services in the field of scientific research laboratories and medical diagnostic laboratories; providing technical support services in the nature of troubleshooting problems with in vitro diagnostic laboratory instruments, laboratory automation systems and for related software and computer hardware; providing electronic remote debugging services being IT services for laboratories in the field of in vitro diagnostic laboratory instruments, laboratory automation systems and for related softwareACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 11, 2025LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Mar 4, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 14, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 14, 2024FIMPFINAL DISPOSITION PROCESSED—
Feb 14, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 27, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 14, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 14, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 29, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 29, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 27, 2023GPNXNOTIFICATION PROCESSED BY IB—
Aug 9, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 9, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 9, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 26, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 26, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 26, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 26, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 9, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 9, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 9, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 2, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 2, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 2, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 20, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Nov 2, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 2, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 5, 2022RFNPREFUSAL PROCESSED BY IB—
Aug 15, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 15, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 15, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 8, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 8, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 8, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 30, 2022RFNTREFUSAL PROCESSED BY IB—
Jan 10, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 10, 2022RFRRREFUSAL PROCESSED BY MPU—
Dec 19, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 18, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 15, 2021DOCKASSIGNED TO EXAMINER—
Jun 8, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 2, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 27, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance